The effects of ketorolac injected via patient controlled analgesia postoperatively on spinal fusion

Yonsei Medical Journal

Volumn 46, Issue 2, 2005, Pages 245-251

  Park, Si Young ^a   Moon, Seong Hwan ^a   Park, Moon Soo ^b   Oh, Kyung Soo ^a   Lee, Hwan Mo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Ketorolac; Lumbar spine; Spinal fusion

Indexed keywords

FENTANYL; KETOROLAC; MORPHINE;

ADULT; AGED; ARTICLE; BONE TRANSPLANTATION; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INFUSION; FEMALE; FRACTURE HEALING; HUMAN; ILIAC BONE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PSEUDARTHROSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPINE FUSION; SPONDYLOLISTHESIS; SURGEON; SURGICAL INSTRUMENT; TREATMENT OUTCOME; VERTEBRAL CANAL STENOSIS;

EID: 18644368965     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.2.245     Document Type: Article

References (30)

1. Moon MS, Ok IY, Lee KS, Yoon HY. A Clinical study of 52 cases of posterolaterally fused lumbar spine. J Korean Orthop Assoc 1986;21:585-94.
2. Kwon H, Kim BK, Song JM, Shin BJ, Na SK. Comparative study of fusion rate in the thoracolumbar and lumbar posterolateral fusion using autograft or xenograft lubboc. J Korean Spine Surg 1997;4:43-51.
3. Scott DB, Jeffery HS, William CH. An experimental lumbar intertransverse process spinal fusion model-radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
4. Kim NH. Anterior interbody fusion in the treatment of the lumbar herniated nucleus pulposus. Yonsei Med J 1999;40:256-64.
5. Bassett CA, Creighton DK. A comparison of host response to cortical autograft and processed calf heterograft. J Bone Joint Surg 1962;44A:842-6.
6. Toth JM, Seim HB, Schwardt JD, Humphrey WD, Wallskog JA, Turner AS. Direct current electrical stimulation increases the fusion rate of spinal fusion cages. Spine 2000;25:2580-7.
7. Martin GJ, Boden S, Titus L. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketoloac, a nonsteroidal anti inflammatory drugs (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine 1999;24:2188-96.
8. Brown CW, Orme TJ, Richardson HD. The rate of pseudoarthrosis in patients who are smokers and patients who are nonsmokers: A comparison study. Spine 1986;11:942-3.
9. Scott SR, Neil RC, Shari L, Margaret K, Charles SG. Dose-response of ketoloac as an adjunct to patient- controlled analgesia morphine in patients after spinal fusion surgery. Anesth Analg 1998;87:98-102.
10. Hernandez PJ, Tortosa JA, Martinez LJ, Perz FD. Intravenous administration of propacetamol reduces morphine consumption after spinal fusion surgery. Anesth Analg 2001;92:1473-6.
11. Kjaersgaard-Anderson P, Schmidt SA. Total hip arthroplasty. The role of anti-inflammatory medications in the prevention of heterotopic ossification. Clin Orthop 1991;263:78-86.
12. Lebwohl NH, Starr JK, Milne EL, Latta LL, Malini TI. Inhibitory effect of ibuprofen on spinal fusion in rabbits. Rosemont, IL: AAOS; 1994. p.278.
13. Dimar JR, Ante WA, Zang YP, Glassman SD. The effects of nonsteroidal anti inflammatory drugs on posterior spinal fusions in rat. Spine 1996;21:1870-6.
14. Glassman SD, Rose SM, Dimar JR, Puno RM, Campcell MJ, Johnson JR. The effect of postoperative nonsteroidal anti-inflammatory drugs administration on spinal fusion. Spine 1998;23:834-8.
15. Turner DM, Warson JS, Wirt TC, Scalley RD, Cochran RS, Miller KJ. The use of Ketololac in lumbar spine surgery: A cost benefit analysis. J Spinal Disord 1995;8: 206-12.
16. Lenke LG, Bridwell KH, BUllis DB, Betz RR, Baldus C, Schoenecker PL. Results of in situ fusion for isthmic spondylolisthesis. J Spinal Disord 1992;5:433-42.
17. Kim NH, Lee JW. Anterior interbody fusion versus posterolateral fusion with transpedicular fixation for isthmic spondylolithesis. Spine 1999;24:812-7.
18. Saag KG, Cowdery JS. Nonsteroidal anti-inflammatory drugs. Balancing benefits and risks. Spine 1994;19:1530-4.
19. Coloma M, White PF, Huber PJ, Kendall TW, Dullye KK, Duffy LL. The effect of ketorolac on recovery after anorectal surgery: Intravenous versus local administration. Anesth Analg 2000;90:1107-10.
20. Daniel R, Jhon L, John R, Stephen L, Timothy K, Kim YJ, et al. Time-dependent inhibitory effects of indomethacin on spine fusion. J Bone Joint Sug 2003;85:632-6.
21. Goodman S, Ma T, Trindade M, Ikenoue T. Cox-2 selective NSAID decrease bone growth in vivo. J Orthop Res 2002;20:1164-72.
22. Long J, Lewis S, Kuklo T, Zhu Y, Riew KD. The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg 2002;84:1763-8.
23. Reuben SS. Considerations in the use of Cox-2 inhibitors in spinal fusion surgery: In response. Anesth Analg 2001;93:803-4.
24. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-5.
25. Hiroshi M, Ryuichi S, Minoru D, Masahiro K, Kosaku M. The role of cyclooxygenase-2 in lumbar disc herniation. Spine 2002;27:2477-83.
26. Brown KM, Saunders MM, Kirsch T, Donahue HJ, Reid JS. Effect of COX-2-specific inhibition on fracture healing in the rat femur. J Bone Joint Surg 2004;86A:116-23.
27. Miyamoto H, Saura R, Doita M, Kurosaka M, Mizuno K. The role of cyclo oxygenase-2 in lumbar disc herniation. Spine 2002;27:2477-83.
28. Glassman SD, Anagnost SC, Parker A, Burke D, Johnson JR, Dimar JR. The effect of cigarette smoking and smoking cessation and spinal fusion. Spine 2000;25: 2608-15.
29. Depalma AF, Prabhaker M. Posterior-posterobilateral fusion of the lumbosacral spine. Clin Orthop 1996;47: 165-73.
30. Carpenter MC, Dietz MJW, Leng KYK, Hanscom DA, Wagner TA. Repair of a pseudoarthrosis of lumbar spine. A functional outcome study. J Bone Joint Surg 1996;78A:712-20.